The appetite-regulating effects of tirzepatide diminish relatively quickly once you stop injecting
Tirzepatide is a dual-receptor peptide studied for activity across GIP and GLP-1 pathways
While better blood sugar control usually helps your eyes long term, the short-term adjustment period carries some risk
Figure 2: Gross expenditures on GLP-1 AOMs in states that recently terminated coverage, in $ millions Gross expenditures for Wegovy, Zepbound, and Saxenda for all approved indications, including reducing the risk of MACE, MASH, and OSA
Heres a breakdown of the common dosing regimen for tirzepatide when used for weight loss
Purpose-built for physicians Tirzepatide led to greater real-world weight loss than semaglutide for adults with obesity Key takeaways: Adults with overweight or obesity using tirzepatide lost more weight than those using semaglutide